eli lilly retatrutide study Today, we shared new data from the latest Phase 3 of retatrutide, an investigational treatment being studied for adults with obesity or overweight with at least one weight-related comorbidity. Learn more ESC 2024: Retatrutide improves lipid

Patients should also ask which ingredient form is being used, as some compounded products may use salt forms that differ from FDA-approved formulations

The medication is typically administered through subcutaneous injections, either at home or at a clinic, and proper guidance on injection techniques and storage will be provided

The use of glucose-lowering agents that provide significant weight loss, particularly GLP-1 RA with high weight loss efficacy, should be considered as they can often provide 1015% weight loss or more

But before drawing any conclusions, there's a question that almost never gets asked first: how hydrated were you when that blood was drawn